Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?

1. Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares soared 29.13% in the last week after reporting that its transfusion-dependent (TD) alpha-or beta-thalassemia study met primary endpoint. Several analysts raised their forecasts after the announcement.
2. Verint Systems Inc. (NASDAQ:VRNT) shares are zoomed 22.40% after the company on Tuesday reported better-than-expected Q1 financial results and issued strong FY25 guidance.
3. Novavax Inc (NASDAQ:NVAX) shares gained 21.54% in the last week after the U.S. Food and Drug Administration’s advisory committee voted to recommend updated vaccines for JN.1-lineage of COVID-19.
4. Nuvalent, Inc. (NASDAQ:NUVL) shares rose 20.52%.
5. Neogen Corporation (NASDAQ:NEOG) shares increased 19.25%.
6. Twist Bioscience Corporation (NASDAQ:TWST) shares jumped 18.40% after Guggenheim initiated coverage on the stock with a Buy rating and announced a price target of $53.
7. Smartsheet Inc. (NYSE:SMAR) shares escalated 18.01% after the company reported better-than-expected Q1 financial results and announced an inaugural $150 million share repurchase program. Many analysts changed their price targets.
8. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock grew 14.03%  after the company raised its FY24 guidance.
9. Legend Biotech Corporation (NASDAQ:LEGN) shares rose 13.93%.
10. Liberty Global Ltd. (NASDAQ:LBTYB) shares upped 12.48%.

Photo via Shutterstock
Also Read: GameStop And NIO Were Among The 11 Biggest Large Cap Losers Last Week (June 1-June 7): Are These In Your Portfolio?